Yu J C, Mahadevan D, LaRochelle W J, Pierce J H, Heidaran M A
Laboratory of Cellular and Molecular Biology, National Cancer Institute, Bethesda, Maryland 20892.
J Biol Chem. 1994 Apr 8;269(14):10668-74.
We have generated two groups of deletion mutants of the alpha PDGFR and one group of chimeras between alpha PDGFR and beta PDGFR to further investigate the structural requirements of the alpha PDGFR for binding to platelet-derived growth factor (PDGF)-AA and to a monoclonal antibody against alpha PDGFR (designated as mAb-alpha R1). The mAb-alpha R1 has recently been reported to block high affinity binding of PDGF-AA to alpha PDGFR. The first group of mutants were carboxyl-terminal deletion mutants encoding the first two immunoglobulin (Ig)-like domains (alpha R1-216), the first four Ig-like domains (alpha R1-415), or all five Ig-like domains (alpha R1-530) of the alpha PDGFR. Since these mutants lacked transmembrane domains, their expression in NIH/3T3 cells resulted in secretion of the truncated alpha PDGFRs. Using conditioned medium from NIH/3T3 transfectants, we showed that mAb-alpha R1 was able to immunoprecipitate each of these secreted form of alpha PDGFRs, suggesting that the epitope recognized by mAb-alpha R1 is located within Ig-like domains 1 and 2 of the alpha PDGFR. Furthermore, PDGF-AA exhibited detectable binding to alpha R1-415 or alpha R1-530 but failed to interact with alpha R1-216, suggesting that the first two Ig-like domains of the alpha PDGFR are not sufficient for PDGF-AA binding. The second group of alpha PDGFR mutants were internal deletion mutants lacking Ig-like loop 1 (alpha R delta 49-100), Ig-like loop 2 (alpha R delta 150-189), Ig-like loop 3 (alpha R delta 235-290), or part of Ig-like loops 4 and 5 (alpha R delta 375-450). The internal deletion mutants were transfected into 32D cells which lack both alpha PDGFR and beta PDGFR. PDGF-AA bound with high affinity to 32D cells expressing alpha R delta 375-450 but not to 32D cells expressing the other three internal deletion mutants, suggesting that the region required for PDGF-AA binding should be within the first three Ig-like domains of the alpha PDGFR. In addition, mAb-alpha R1 bound to 32D cells expressing alpha R delta 235-290 but failed to bind 32D cells transfected with alpha R delta 49-100 or alpha R delta 150-189.(ABSTRACT TRUNCATED AT 400 WORDS)
我们构建了两组α血小板衍生生长因子受体(α PDGFR)缺失突变体以及一组α PDGFR与β PDGFR之间的嵌合体,以进一步研究α PDGFR与血小板衍生生长因子(PDGF)-AA及抗α PDGFR单克隆抗体(命名为mAb-α R1)结合的结构要求。最近有报道称mAb-α R1可阻断PDGF-AA与α PDGFR的高亲和力结合。第一组突变体是羧基末端缺失突变体,分别编码α PDGFR的前两个免疫球蛋白(Ig)样结构域(α R1-216)、前四个Ig样结构域(α R1-415)或全部五个Ig样结构域(α R1-530)。由于这些突变体缺乏跨膜结构域,则其在NIH/3T3细胞中的表达会导致截短型α PDGFR的分泌。利用NIH/3T3转染细胞的条件培养基,我们发现mAb-α R1能够免疫沉淀这些分泌形式的α PDGFR中的每一种,这表明mAb-α R1识别的表位位于α PDGFR的Ig样结构域1和2内。此外,PDGF-AA可检测到与α R1-415或α R1-530结合,但不能与α R1-216相互作用,这表明α PDGFR的前两个Ig样结构域不足以实现PDGF-AA的结合。第二组α PDGFR突变体是内部缺失突变体,分别缺失Ig样环1(α R delta 49-100)、Ig样环2(α R delta 150-189)、Ig样环3(α R delta 235-290)或Ig样环4和5的一部分(α R delta 375-450)。将这些内部缺失突变体转染到既缺乏α PDGFR又缺乏β PDGFR的32D细胞中。PDGF-AA与表达α R delta 375-450的32D细胞高亲和力结合,但不与表达其他三种内部缺失突变体的32D细胞结合,这表明PDGF-AA结合所需区域应在α PDGFR的前三个Ig样结构域内。此外,mAb-α R1与表达α R delta 235-290的32D细胞结合,但不与转染了α R delta 又49-100或α R delta 150-189的32D细胞结合。(摘要截选至400字)